Page 132 - Read Online

Zahrai et al. Vessel Plus 2023;7:32 https://dx.doi.org/10.20517/2574-1209.2023.100 Page 13 of 13

53. Ebrahimi R, Dyke C, Mehran R, et al. Outcomes following pre-operative clopidogrel administration in patients with acute coronary
syndromes undergoing coronary artery bypass surgery: the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY)
trial. J Am Coll Cardiol 2009;53:1965-72. DOI
54. Fox KA, Mehta SR, Peters R, et al; Clopidogrel in unstable angina to prevent recurrent ischemic events trial. Benefits and risks of the
combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary
syndrome: the clopidogrel in unstable angina to prevent recurrent ischemic events (CURE) Trial. Circulation 2004;110:1202-8. DOI
55. Smith PK, Goodnough LT, Levy JH, et al. Mortality benefit with prasugrel in the TRITON-TIMI 38 coronary artery bypass grafting
cohort: risk-adjusted retrospective data analysis. J Am Coll Cardiol 2012;60:388-96. DOI PubMed PMC
56. Valgimigli M, Bueno H, Byrne RA, et al. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed
in collaboration with EACTS. Kardiol Pol 2017;75:1217-99. DOI
57. Mehta SR, Bainey KR, Cantor WJ, et al; members of the Secondary Panel. 2018 Canadian cardiovascular society/Canadian association
of interventional cardiology focused update of the guidelines for the use of antiplatelet therapy. Can J Cardiol 2018;34:214-33. DOI
58. Gherli R, Mariscalco G, Dalén M, et al. Safety of preoperative use of ticagrelor with or without aspirin compared with aspirin alone in
patients with acute coronary syndromes undergoing coronary artery bypass grafting. JAMA Cardiol 2016;1:921-8. DOI PubMed
59. Schultz-Lebahn A, Nissen PH, Pedersen TF, Tang M, Hvas AM. Platelet function assessed by ROTEM(®)platelet in patients receiving
antiplatelet therapy during cardiac and vascular surgery. Scand J Clin Lab Invest 2022;82:18-27. DOI PubMed
60. Sibbing D, Aradi D, Alexopoulos D, et al. Updated expert consensus statement on platelet function and genetic testing for guiding
p2Y(12) receptor inhibitor treatment in percutaneous coronary intervention. JACC Cardiovasc Interv 2019;12:1521-37. DOI PubMed
61. Bhatt DL, Pollack CV, Weitz JI, et al. Antibody-based ticagrelor reversal agent in healthy volunteers. N Engl J Med 2019;380:1825-
33. DOI
62. Bhatt DL, Pollack CV, Mazer CD, et al. Bentracimab for ticagrelor reversal in patients undergoing urgent surgery. NEJM Evidence
2022;1:3. DOI
63. Douketis JD, Spyropoulos AC, Spencer FA, et al. Perioperative management of antithrombotic therapy: antithrombotic therapy and
prevention of thrombosis, 9th ed: American college of chest physicians evidence-based clinical practice guidelines. Chest
2012;141:e326S-50S. DOI PubMed
64. Alquwaizani M, Buckley L, Adams C, Fanikos J. Anticoagulants: a review of the pharmacology, dosing, and complications. Curr
Emerg Hosp Med Rep 2013;1:83-97. DOI PubMed PMC
65. Hochman JS, Sleeper LA, Webb JG, et al. Early revascularization in acute myocardial infarction complicated by cardiogenic shock.
SHOCK investigators. Should we emergently revascularize occluded coronaries for cardiogenic shock. N Engl J Med 1999;341:625-
34. DOI PubMed